This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Endpoint definition
↥
FinnGen phenotype data
429209 individuals
Apply sex-specific rule None
429209
Check conditions None
429209
Check pre-conditions, main-only, mode, registry filters
Cancer registry: Topography ICD-O-3
ANY
Cancer registry: Morphology ICD-O-3
9680
Cancer registry: Behaviour codes
3
1 out of 7 registries used, show all original rules.
1077
Check minimum number of events None
1077
Include endpoints None
1077
Remove individuals based on genotype QC
1050
HLP_C3_DLBCL
Control definitions
Control exclude
C3_CANCER, C3_CANCER_WIDE
Extra metadata
First used in FinnGen datafreeze
DF8
Show upset plot detailing case counts by codes
Or the full data table
Similar endpoints
↥List of similar endpoints to
Diffuse large B-cell lymphoma
based on the number of shared cases.
Broader endpoints:
- Diffuse large B-cell lymphoma
- Diffuse large B-cell lymphoma (controls excluding all cancers)
- Any event in cancer register
- Malignant neoplasm
- Malignant neoplasm (controls excluding all cancers)
Narrower endpoints:
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1050 | 454 | 596 |
| Unadjusted prevalence (%) | 0.25 | 0.20 | 0.33 |
| Mean age at first event (years) | 65.59 | 63.61 | 67.10 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: HLP_C3_DLBCL – Diffuse large B-cell lymphoma
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Diffuse large B-cell lymphoma
↥Endpoint not on priority list, no data to show.